Last updated: May 3, 2024
Sponsor: Mansoura University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Mastectomy
Pain
Acute Pain
Treatment
Stellate gangalion block
Clinical Study ID
NCT06263907
stellate ganglion block
Ages 21-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Female patients
- Age ranging from 18 to 65 years
- American Society of Anesthesiologists (ASA) no more than II
- Had unilateral cancer breast
- Scheduled to do unilateral modified radical mastectomy
Exclusion
Exclusion Criteria:
- Pregnant female
- Existing Horner syndrome
- Had any neuromuscular disease
- Had allergy to local anesthetics
- History of use of analgesics
- Had any deformity or a previous surgery in the neck or ipsilateral arm or breast
- Had any contraindication to the procedure (coagulation disorders, local infection,sepsis)
- Had any contraindication to the sympathetic blockade (decompensate cardiopulmonary orhemodynamic disorders)
- History of psychotic disorder including depression, bipolar disorder or personalitydisorder
- Patient with Beck Depression Inventory (BDI) score more than 13
Study Design
Total Participants: 140
Treatment Group(s): 1
Primary Treatment: Stellate gangalion block
Phase:
Study Start date:
March 01, 2024
Estimated Completion Date:
December 30, 2025
Study Description
Connect with a study center
Maha
Mansoura,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.